Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-04-23
1994-03-15
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514260, 544284, 544287, A61K 31505, C07D23990, C07D23991
Patent
active
052946177
ABSTRACT:
This disclosure describes novel 2, 3, 6 substituted quinazolinones having the formula ##STR1## wherein R.sup.6, X and R are defined in the specification which have activity as angiotensin II (AII) antagonists.
REFERENCES:
patent: 5202322 (1993-04-01), Allen et al.
Levin Jeremy I,
Venkatesan Aranapakam M.
American Cyanamid Company
Grumbling Matthew Y.
Shah Mukund J.
Szatkowski T. S.
LandOfFree
Angiotensin II receptor blocking 2,3,6 substituted quinazolinone does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiotensin II receptor blocking 2,3,6 substituted quinazolinone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiotensin II receptor blocking 2,3,6 substituted quinazolinone will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1536221